MeVis Medical Solutions AG

As of March 31, 2020, MeVis Medical Solutions AG carries a market capitalization of 49.50M, placing it among publicly traded companies globally. Its enterprise value stands at 46.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2020, MeVis Medical Solutions AG has 1.82M shares outstanding.

These figures are as of March 31, 2020.

As of March 31, 2020, MeVis Medical Solutions AG maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2020.

Over the twelve months ended March 31, 2020, MeVis Medical Solutions AG recorded 85,000.00 in income tax expense.

As of the close on October 22, 2026, MeVis Medical Solutions AG's stock has declined approximately 12.50% over the past 52 weeks. The 50-day moving average sits at 22.55, while the 200-day moving average is 23.27.

These figures are as of March 31, 2020. Total book value stands at 17.83M, with working capital of 3.18M providing operational flexibility.

These figures cover the twelve months ended March 31, 2020.